Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Naresh Mandava to Retinitis Pigmentosa

This is a "connection" page, showing publications Naresh Mandava has written about Retinitis Pigmentosa.

 
Connection Strength
 
 
 
0.611
 
  1. Prall FR, Drack A, Taylor M, Ku L, Olson JL, Gregory D, Mestroni L, Mandava N. Ophthalmic manifestations of Danon disease. Ophthalmology. 2006 Jun; 113(6):1010-3.
    View in: PubMed
    Score: 0.269
  2. Jackson TL, Mandava N, Quiroz-Mercado H, Benage M, Garcia-Aguirre G, Morales-Canton V, Wilbur L, Olson J. Intravitreal quantum dots for retinitis pigmentosa: a first-in-human safety study. Nanomedicine (Lond). 2021 04; 16(8):617-626.
    View in: PubMed
    Score: 0.187
  3. Gregori NZ, Callaway NF, Hoeppner C, Yuan A, Rachitskaya A, Feuer W, Ameri H, Arevalo JF, Augustin AJ, Birch DG, Dagnelie G, Grisanti S, Davis JL, Hahn P, Handa JT, Ho AC, Huang SS, Humayun MS, Iezzi R, Jayasundera KT, Kokame GT, Lam BL, Lim JI, Mandava N, Montezuma SR, Olmos de Koo L, Szurman P, Vajzovic L, Wiedemann P, Weiland J, Yan J, Zacks DN. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study. Am J Ophthalmol. 2018 09; 193:87-99.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)